|
INTS4L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.991200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.139000E-01 |
| Normal-vs-Stage2 |
4.856200E-01 |
| Normal-vs-Stage3 |
2.350800E-01 |
| Normal-vs-Stage4 |
1.872060E-02 |
| Stage1-vs-Stage2 |
4.539000E-01 |
| Stage1-vs-Stage3 |
2.436200E-01 |
| Stage1-vs-Stage4 |
2.336500E-02 |
| Stage2-vs-Stage3 |
2.185200E-01 |
| Stage2-vs-Stage4 |
5.467900E-02 |
| Stage3-vs-Stage4 |
2.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.130000E-01 |
| Normal-vs-AfricanAmerican |
3.067000E-01 |
| Normal-vs-Asian |
1.782370E-01 |
| Caucasian-vs-AfricanAmerican |
1.332440E-01 |
| Caucasian-vs-Asian |
4.144600E-01 |
| AfricanAmerican-vs-Asian |
2.764000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.790000E-01 |
| Normal-vs-Female |
3.147200E-01 |
| Male-vs-Female |
1.269590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.031000E-01 |
| Normal-vs-Extreme_Weight |
1.866450E-01 |
| Normal-vs-Obese |
8.492600E-01 |
| Normal-vs-Extreme_Obese |
9.565000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.072600E-01 |
| Normal_Weight-vs-Obese |
5.740600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.482200E-01 |
| Extreme_Weight-vs-Obese |
2.269200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.872800E-01 |
| Obese-vs-Extreme_Obese |
8.534000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.736400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.976400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.847400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.009800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.944800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.918000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.323800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.297960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.383600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.580200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.750400E-01 |
| Normal-VS-Type2 PRCC |
5.143800E-01 |
| Normal-VS-KIRP CIMP |
5.567400E-01 |
| Normal-VS-Unclassified PRCC |
1.566990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.584000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.672200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.027040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.825400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.319600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.092200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.325600E-01 |
| Normal-vs-N1 |
6.417600E-01 |
| Normal-vs-N2 |
6.255800E-02 |
| N0-vs-N1 |
7.659800E-01 |
| N0-vs-N2 |
2.127800E-01 |
| N1-vs-N2 |
2.579200E-01 |
|
|
